| scholarly article | Q13442814 |
| P50 | author | Marco Bonomi | Q42775119 |
| Ulla Feldt-Rasmussen | Q57422236 | ||
| Nadia Schoenmakers | Q61286978 | ||
| P2093 | author name string | Eric Fliers | |
| Luca Persani | |||
| Georg Brabant | |||
| A S Paul van Trotsenburg | |||
| Mehul Dattani | |||
| Dominique Maiter | |||
| Annette Gruters | |||
| P2860 | cites work | Central Hypothyroidism: Pathogenic, Diagnostic, and Therapeutic Challenges | Q22306204 |
| 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism | Q22306402 | ||
| GRADE: an emerging consensus on rating quality of evidence and strength of recommendations | Q27860753 | ||
| The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH Index | Q28235583 | ||
| A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene | Q28237420 | ||
| Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement | Q28279078 | ||
| Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement | Q28649731 | ||
| Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study | Q33387458 | ||
| Levothyroxine replacement therapy in central hypothyroidism: a practice report | Q33604232 | ||
| Hyperplastic pituitary gland, high serum glycoprotein hormone alpha-subunit, and variable circulating thyrotropin (TSH) levels as hallmark of central hypothyroidism due to mutations of the TSH beta gene. | Q33942043 | ||
| Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease | Q34182395 | ||
| Cranial irradiation and central hypothyroidism | Q34221244 | ||
| AGREE II: advancing guideline development, reporting and evaluation in health care | Q34403979 | ||
| The spectrum of thyroid diseases in childhood and its evolution during transition to adulthood: natural history, diagnosis, differential diagnosis and management | Q34444307 | ||
| Drugs that suppress TSH or cause central hypothyroidism | Q35014743 | ||
| Central hypothyroidism in a patient with pituitary autoimmunity: evidence for TSH-independent thyroid hormone synthesis | Q35744495 | ||
| Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism | Q74619262 | ||
| Neonatal screening for congenital hypothyroidism in the Netherlands: cognitive and motor outcome at 10 years of age | Q79428650 | ||
| Diagnosis of subclinical central hypothyroidism in patients with hypothalamic-pituitary disease by Doppler echocardiography | Q83300922 | ||
| Treatment of central hypothyroidism | Q83972831 | ||
| The severity of congenital hypothyroidism of central origin should not be underestimated | Q85861628 | ||
| European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism | Q87506594 | ||
| GENETICS IN ENDOCRINOLOGY: Genetic diagnosis of endocrine diseases by NGS: novel scenarios and unpredictable results and risks | Q89031357 | ||
| Mortality in Children With Early-Detected Congenital Central Hypothyroidism | Q89061085 | ||
| Screening for central hypothyroidism is unjustified | Q95815966 | ||
| A Novel Thyrotropin-Releasing Hormone Receptor Missense Mutation (P81R) in Central Congenital Hypothyroidism. | Q36716112 | ||
| Congenital thyrotropin deficiency--from discovery to molecular biology, postgenome and preventive medicine | Q36730990 | ||
| IGSF1 Deficiency: Lessons From an Extensive Case Series and Recommendations for Clinical Management | Q36935601 | ||
| Mechanisms related to the pathophysiology and management of central hypothyroidism | Q37305405 | ||
| Mutations in TBL1X Are Associated With Central Hypothyroidism. | Q37502569 | ||
| Pituitary transcription factors in the aetiology of combined pituitary hormone deficiency | Q37852201 | ||
| Mass screening of newborns for congenital hypothyroidism of central origin by free thyroxine measurement of blood samples on filter paper | Q38460304 | ||
| Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients | Q38915592 | ||
| Central hypothyroidism - a neglected thyroid disorder | Q39332895 | ||
| The multiple genetic causes of central hypothyroidism. | Q39397192 | ||
| Constitutively Active Thyrotropin and Thyrotropin-Releasing Hormone Receptors and Their Inverse Agonists | Q39635722 | ||
| Thyrotropin Secretion in Patients with Central Hypothyroidism: Evidence for Reduced Biological Activity of Immunoreactive Thyrotropin* | Q39665821 | ||
| New reference charts for testicular volume in Dutch children and adolescents allow the calculation of standard deviation scores. | Q41460780 | ||
| Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism. | Q42480377 | ||
| Circadian and stimulated thyrotropin secretion in cranially irradiated adult cancer survivors | Q42484879 | ||
| Circulating thyrotropin bioactivity in sporadic central hypothyroidism. | Q42495450 | ||
| Measurement of cAMP accumulation in Chinese hamster ovary cells transfected with the recombinant human TSH receptor (CHO-R): a new bioassay for human thyrotropin. | Q42502352 | ||
| Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine | Q42598771 | ||
| Two novel mutations of the TSH-beta subunit gene underlying congenital central hypothyroidism undetectable in neonatal TSH screening | Q43037133 | ||
| Newborn screening results in children with central hypothyroidism | Q43132977 | ||
| Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone | Q43431522 | ||
| Pitfalls in the use of thyrotropin concentration as a first-line thyroid-function test | Q43568747 | ||
| Increased need for thyroxine in women with hypothyroidism during estrogen therapy | Q43632572 | ||
| Incidence of elevation of serum thyroid-stimulating hormone during controlled ovarian hyperstimulation for in vitro fertilization | Q43854425 | ||
| Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism | Q44248945 | ||
| Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients | Q44720610 | ||
| Optimal free thyroxine levels for thyroid hormone replacement in hypothyroidism | Q46407372 | ||
| Monitoring therapy in patients taking levothyroxine | Q46483692 | ||
| Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013-2015). | Q47550213 | ||
| Novel FOXA2 mutation causes Hyperinsulinism, Hypopituitarism with Craniofacial and Endoderm-derived organ abnormalities | Q49653037 | ||
| Mean high dose L-thyroxine treatment is efficient and safe to achieve a normal IQ in young adult patients with congenital hypothyroidism. | Q50084495 | ||
| Median-lower normal levels of serum thyroxine are associated with low triiodothyronine levels and body temperature in patients with central hypothyroidism. | Q50552545 | ||
| Central Hypothyroidism Due to a TRHR Mutation Causing Impaired Ligand Affinity and Transactivation of Gq. | Q51051654 | ||
| A family with complete resistance to thyrotropin-releasing hormone. | Q51824584 | ||
| Thyroid Hormone Replacement for Central Hypothyroidism: A Randomized Controlled Trial Comparing Two Doses of Thyroxine (T4) with a Combination of T4and Triiodothyronine | Q56964382 | ||
| A Case for Clarity, Consistency, and Helpfulness: State-of-the-Art Clinical Practice Guidelines in Endocrinology Using the Grading of Recommendations, Assessment, Development, and Evaluation System | Q57269343 | ||
| Thyrotropin with decreased biological activity, a delayed consequence of cranial irradiation for nasopharyngeal carcinoma | Q71488626 | ||
| Bioactivity of thyrotropin (TSH) in patients with central hypothyroidism: comparison between in vivo 3,5,3'-triiodothyronine response to TSH and in vitro bioactivity of TSH | Q72149681 | ||
| Diagnosis of hidden central hypothyroidism in survivors of childhood cancer | Q73276397 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 13 | |
| P304 | page(s) | 225-237 | |
| P577 | publication date | 2018-07-19 | |
| P1433 | published in | European thyroid journal : official journal of the European Thyroid Association | Q26853784 |
| P1476 | title | 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism | |
| P478 | volume | 7 |
| Q92432488 | EUROPEAN THYROID ASSOCIATION (ETA) GUIDELINES FOR CENTRAL HYPOTHYROIDISM |
| Q90095594 | Endocrine morbidity in midline brain defects: Differences between septo-optic dysplasia and related disorders |
| Q57853845 | Interactions between hypothalamic pituitary thyroid axis and other pituitary dysfunctions |
| Q90213933 | Novel MTTP Gene Mutation in a Case of Abetalipoproteinemia with Central Hypothyroidism |
| Q90539729 | Syndromes of Resistance to Thyroid Hormone Action |
| Q61816694 | The diagnosis and management of central hypothyroidism in 2018 |
Search more.